Discovery of molecular determinants of response to targeted therapies in colorectal cancer using patient-derived xenografts (‘xenopatients’)

Por Sassi, Francesco, Migliardi, Giorgia, Zanella, Eugenia, Galimi, Francesco, Cottino, Francesca, Bertotti, Andrea, Trusolino, Livio
Publicado em 2013

HER2 activating mutations are targets for colorectal cancer treatment

Por Kavuri, Shyam M., Jain, Naveen, Galimi, Francesco, Cottino, Francesca, Leto, Simonetta M., Migliardi, Giorgia, Searleman, Adam C., Shen, Wei, Monsey, John, Trusolino, Livio, Jacobs, Samuel A., Bertotti, Andrea, Bose, Ron
Publicado no Cancer Discov (2015)

The Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer

Por Bertotti, Andrea, Papp, Eniko, Jones, Siân, Adleff, Vilmos, Anagnostou, Valsamo, Lupo, Barbara, Sausen, Mark, Phallen, Jillian, Hruban, Carolyn A., Tokheim, Collin, Niknafs, Noushin, Nesselbush, Monica, Lytle, Karli, Sassi, Francesco, Cottino, Francesca, Migliardi, Giorgia, Zanella, Eugenia R., Ribero, Dario, Russolillo, Nadia, Mellano, Alfredo, Muratore, Andrea, Paraluppi, Gianluca, Salizzoni, Mauro, Marsoni, Silvia, Kragh, Michael, Lantto, Johan, Cassingena, Andrea, Li, Qing Kay, Karchin, Rachel, Scharpf, Robert, Sartore-Bianchi, Andrea, Siena, Salvatore, Diaz, Luis A., Trusolino, Livio, Velculescu, Victor E.
Publicado no Nature (2015)